Omicron can evade Covid vaccine protection, antibody therapies: Study

Omicron can evade the immune protection conferred by Covid-19 vaccines and natural infection, according to a peer-reviewed study which also suggests that the new variant of coronavirus is completely resistant to antibody therapies in use today. The study, published on Thursday, also highlights the need for new vaccines and treatments that anticipate how the SARS-CoV-2 virus may soon evolve.